Hepatitis A: Symptoms, Causes & Complete Treatment Guide

Medically reviewed | Last reviewed: | Evidence level: 1A
Hepatitis A is a highly contagious liver infection caused by the hepatitis A virus (HAV). The disease typically spreads through contaminated food and water or close contact with an infected person. While hepatitis A can cause severe illness lasting weeks to months, it does not become a chronic infection and rarely causes long-term liver damage. Vaccination provides effective protection.
📅 Updated:
⏱️ Reading time: 12 minutes
Written and reviewed by iMedic Medical Editorial Team | Specialists in gastroenterology and infectious diseases

📊 Quick facts about Hepatitis A

Global Cases
1.4 million/year
Worldwide annually
Incubation Period
2-6 weeks
Average 4 weeks
Vaccine Efficacy
>95%
Protection after 2 doses
Recovery Time
2-3 weeks
to 3 months full recovery
Chronic Infection
Never
HAV does not become chronic
ICD-10 Code
B15
SNOMED CT: 40468003

💡 The most important things you need to know

  • Hepatitis A is preventable: The hepatitis A vaccine provides >95% protection and is recommended before traveling to endemic regions
  • Self-limiting disease: Unlike hepatitis B and C, hepatitis A does not become chronic and most people recover fully within 3 months
  • Most contagious before symptoms: You are most infectious about 2 weeks before and 1 week after symptoms appear
  • Jaundice is a key symptom: Yellowing of the skin and eyes (jaundice) typically appears about 1 week after initial flu-like symptoms
  • Lifelong immunity: Once you've had hepatitis A, you cannot get it again – you develop permanent immunity
  • Avoid alcohol during recovery: Your liver needs rest – avoid alcohol for at least 3 months and consult your doctor about medications

What Is Hepatitis A?

Hepatitis A is a viral infection of the liver caused by the hepatitis A virus (HAV). It causes inflammation that temporarily impairs liver function. Unlike hepatitis B and C, hepatitis A never becomes a chronic infection and most people make a full recovery within 2-3 months without any long-term liver damage.

The liver is one of the body's most important organs, responsible for filtering blood, storing nutrients, producing bile for digestion, and breaking down toxins including medications and alcohol. When hepatitis A virus infects the liver, it causes inflammation that temporarily disrupts these vital functions. This inflammation is what causes the characteristic symptoms of the disease, including fatigue, nausea, and the yellowing of the skin and eyes known as jaundice.

Hepatitis A is one of several types of viral hepatitis, each caused by a different virus. While hepatitis B and C can become chronic, long-term infections, hepatitis A is always an acute, short-term illness. This is a crucial distinction because chronic viral hepatitis can lead to serious complications like cirrhosis and liver cancer, whereas hepatitis A, despite potentially causing severe acute illness, does not cause long-term liver damage in the vast majority of cases.

The disease is most common in regions with poor sanitation and limited access to clean water, including parts of Africa, Asia, Central and South America, Eastern Europe, and the Middle East. In developed countries with high hygiene standards, hepatitis A is less common, but outbreaks can still occur, particularly associated with contaminated food or among certain population groups.

Why is it called "infectious hepatitis"?

Hepatitis A is sometimes referred to as "infectious hepatitis" or "epidemic jaundice" because of its highly contagious nature and the characteristic yellow discoloration of the skin it causes. Before the development of modern diagnostic tests, doctors distinguished between different types of hepatitis primarily based on how they spread – hepatitis A through the fecal-oral route (infectious hepatitis) and hepatitis B through blood and body fluids (serum hepatitis).

Types of viral hepatitis

There are five main types of viral hepatitis, designated A through E. Each is caused by a different virus with distinct characteristics:

Comparison of different types of viral hepatitis
Type Transmission Chronic Infection Vaccine Available
Hepatitis A Fecal-oral (food/water) Never Yes
Hepatitis B Blood, sexual contact, mother to child Yes (5-10% of adults) Yes
Hepatitis C Blood (primarily injection drug use) Yes (75-85%) No
Hepatitis D Blood (requires HBV co-infection) Yes HBV vaccine protects
Hepatitis E Fecal-oral (contaminated water) Rarely (immunocompromised) Limited availability

What Are the Symptoms of Hepatitis A?

Hepatitis A symptoms develop gradually over 2-6 weeks after exposure. Initial symptoms resemble the flufever, fatigue, loss of appetite, nausea, and body aches. After about one week, jaundice (yellowing of skin and eyes) typically appears along with dark urine and pale stools. Many children under 5 have no symptoms at all.

The symptoms of hepatitis A vary considerably from person to person. Age is the most important factor – young children often have no symptoms or only mild illness, while adults are more likely to develop severe symptoms. Approximately 70-80% of adults with hepatitis A develop symptoms, compared to only about 30% of children under age 6. However, even people without symptoms can spread the virus to others.

The incubation period – the time between exposure to the virus and the onset of symptoms – ranges from 15 to 50 days, with an average of about 28 days (4 weeks). This relatively long incubation period is one reason why hepatitis A outbreaks can be difficult to trace and control.

Early Symptoms (Prodromal Phase)

The first symptoms of hepatitis A are often non-specific and can be mistaken for influenza or other viral infections. This prodromal phase typically lasts from a few days to about one week. During this time, you may experience:

  • Fatigue and weakness: Often severe and one of the most persistent symptoms
  • Fever: Usually low-grade (38-39°C/100-102°F)
  • Loss of appetite: May be accompanied by nausea and aversion to certain foods
  • Nausea and vomiting: Particularly in the morning or after eating
  • Abdominal discomfort: Especially in the upper right area where the liver is located
  • Muscle and joint pain: Similar to flu symptoms
  • Headache: Mild to moderate

Jaundice Phase (Icteric Phase)

About one week after the initial symptoms, most adults develop jaundice – a yellowing of the skin and the whites of the eyes. This phase can last from 1-3 weeks in mild cases to several months in more severe cases. The jaundice is caused by the buildup of bilirubin, a yellow pigment normally processed by the liver, in the blood and tissues.

When the liver is inflamed and not functioning properly, it cannot effectively remove bilirubin from the blood. This leads to characteristic changes that are often the most obvious signs of hepatitis:

  • Jaundice (icterus): Yellow discoloration of the skin, most visible in people with lighter skin tones. In people with darker skin, jaundice may be harder to see on the skin but is usually visible in the whites of the eyes (sclera)
  • Dark urine: Urine becomes dark amber or tea-colored due to excess bilirubin
  • Pale or clay-colored stools: Stool becomes lighter than normal because bilirubin is not reaching the intestines
  • Itching (pruritus): Can be severe and is caused by bile salts depositing in the skin
  • Tender, enlarged liver: The liver may be palpable and tender in the right upper abdomen
When jaundice appears, other symptoms often improve:

Interestingly, many people notice that their initial flu-like symptoms – such as fever, nausea, and body aches – begin to improve once jaundice develops. However, fatigue often persists for weeks or even months after other symptoms have resolved.

Recovery Phase (Convalescent Phase)

Most people begin to feel better within 2-3 weeks of symptom onset. The jaundice gradually fades, appetite returns, and energy levels improve. However, complete recovery can take time:

  • Most symptoms resolve within 2 months
  • Complete liver recovery typically occurs within 3 months
  • Fatigue may persist for several months after other symptoms resolve
  • About 10-15% of people experience relapsing symptoms over 6-9 months

How Does Hepatitis A Spread?

Hepatitis A spreads through the fecal-oral route – when the virus from an infected person's stool enters another person's mouth. This typically happens through contaminated food or water, or through close personal contact with an infected person. You cannot get hepatitis A from casual contact like shaking hands or sharing an office.

Understanding how hepatitis A spreads is crucial for prevention. The virus is found in the stool (feces) of infected people, often in high concentrations. Even microscopic amounts of contaminated fecal matter can contain enough virus to cause infection. The virus is remarkably resilient – it can survive for months in the environment and is resistant to many common disinfection methods.

A person with hepatitis A is most contagious during the two weeks before symptoms appear and for about one week after jaundice develops. This is particularly problematic because people are spreading the virus before they even know they're infected, and young children – who often have no symptoms – can unknowingly spread the virus for extended periods.

Main Routes of Transmission

Contaminated Food and Water: This is the most common route of transmission globally. Food can become contaminated if it's prepared by someone with hepatitis A who didn't wash their hands properly after using the bathroom. Water can be contaminated by sewage. Common sources include:

  • Raw or undercooked shellfish: Oysters, clams, and mussels can concentrate the virus if harvested from contaminated waters
  • Fresh produce: Fruits and vegetables that are eaten raw and may have been irrigated with contaminated water or handled by infected food workers
  • Ice and drinks: Made with contaminated water
  • Frozen berries: Have been implicated in several outbreaks when imported from endemic areas

Close Personal Contact: Hepatitis A can spread through close contact with an infected person, including:

  • Caring for someone with hepatitis A
  • Sexual contact (particularly oral-anal contact)
  • Living in the same household
  • Sharing illicit drugs (both injection and non-injection)
Important: Animals cannot spread hepatitis A

Hepatitis A is exclusively a human disease. You cannot get hepatitis A from your pets, and animals in nature do not carry the virus. However, shellfish and other filter-feeding organisms can concentrate the virus from contaminated water without being infected themselves.

High-Risk Regions

Hepatitis A is most common in regions with poor sanitation and limited access to clean water. Risk varies significantly by region:

  • High risk: Most of Africa, Asia, Central and South America, Eastern Europe, the Middle East
  • Intermediate risk: Southern and Eastern Europe, some areas of the Middle East
  • Low risk: Western Europe, North America, Australia, New Zealand, Japan

How Is Hepatitis A Diagnosed?

Hepatitis A is diagnosed through blood tests that detect antibodies against the virus. The IgM anti-HAV test identifies current or recent infection, while IgG anti-HAV indicates past infection or vaccination. Liver function tests (ALT, AST, bilirubin) help assess the degree of liver inflammation.

If you have symptoms suggesting hepatitis A, or if you've been exposed to someone with the infection, your healthcare provider will likely order blood tests to confirm the diagnosis. The clinical symptoms of hepatitis A overlap significantly with other types of hepatitis and liver diseases, making laboratory testing essential for accurate diagnosis.

Blood Tests for Hepatitis A

Anti-HAV IgM: This is the primary test for diagnosing acute hepatitis A infection. IgM antibodies appear early in the infection (usually within 2-4 weeks of exposure) and remain detectable for about 3-6 months. A positive IgM anti-HAV test indicates current or recent infection.

Anti-HAV IgG: These antibodies develop after the acute phase and persist for life, providing permanent immunity. A positive IgG with negative IgM indicates past infection or vaccination – you're now immune to hepatitis A.

Liver Function Tests: These blood tests measure substances that indicate how well the liver is functioning:

  • ALT (alanine aminotransferase): Enzyme released when liver cells are damaged. Often elevated 10-100 times normal in acute hepatitis A
  • AST (aspartate aminotransferase): Another liver enzyme, though less specific to the liver than ALT
  • Bilirubin: Elevated levels cause jaundice. Both total and direct bilirubin may be measured
  • Alkaline phosphatase: May be mildly elevated
  • PT/INR: Measures blood clotting function, which depends on liver-produced proteins

How Is Hepatitis A Treated?

There is no specific antiviral treatment for hepatitis A. Treatment focuses on supportive care – rest, adequate nutrition, staying hydrated, and avoiding substances that stress the liver like alcohol and certain medications. Most people recover completely within 2-3 months with proper rest and care.

Unlike some other viral infections, there is no medication that directly kills or inhibits the hepatitis A virus. The good news is that your immune system will eventually clear the infection on its own. Treatment therefore focuses on supporting your body while it fights off the virus and allowing your liver time to heal.

Supportive Care at Home

Rest: Fatigue is often the most prominent and persistent symptom. Listen to your body and rest as needed. Many people need to take time off work during the acute phase, though the duration varies considerably from person to person.

Nutrition: Although loss of appetite and nausea are common, maintaining adequate nutrition is important for recovery. Consider these strategies:

  • Eat small, frequent meals rather than large ones
  • Choose easily digestible foods
  • Focus on nutrient-dense options when appetite allows
  • Avoid fatty and greasy foods, which may worsen nausea
  • Stay well hydrated – water, clear broths, and electrolyte drinks can help
Critical: Avoid alcohol and be cautious with medications

Your liver is already working hard to fight the infection and heal itself. Alcohol must be avoided completely for at least 3 months, as it adds additional stress to the liver. Many medications, including common over-the-counter drugs like acetaminophen (paracetamol), are processed by the liver and may need to be avoided or used at reduced doses. Always consult your healthcare provider before taking any medication during recovery.

When Hospitalization Is Needed

Most people with hepatitis A can recover at home. However, hospitalization may be necessary if you:

  • Cannot keep fluids down due to severe nausea and vomiting
  • Show signs of dehydration
  • Develop signs of liver failure (confusion, bleeding problems, extreme fatigue)
  • Have a pre-existing liver condition
  • Are elderly or have other health conditions that increase complication risk

How Can You Prevent Hepatitis A?

The hepatitis A vaccine is the most effective prevention, providing greater than 95% protection after two doses given 6-12 months apart. Good hand hygiene, safe food practices, and avoiding potentially contaminated water are also essential, especially when traveling to endemic areas.

Hepatitis A is one of the most preventable viral infections thanks to highly effective vaccines and straightforward hygiene measures. Understanding and implementing prevention strategies is crucial, especially for people in high-risk groups or those traveling to areas where the disease is common.

Hepatitis A Vaccination

The hepatitis A vaccine is safe, highly effective, and provides long-lasting protection. Two types of vaccines are available:

Inactivated hepatitis A vaccine: Given as two doses 6-12 months apart. After the first dose, protection begins within 2-4 weeks and reaches greater than 95% after the second dose. Protection is believed to last at least 20-25 years, possibly lifelong.

Combined hepatitis A/B vaccine: Protects against both hepatitis A and B. Given as three doses over 6 months (0, 1, and 6 months) or on an accelerated schedule for travelers.

Who should be vaccinated:

  • All children at age 1 year (as part of routine childhood immunization in many countries)
  • Travelers to countries where hepatitis A is common
  • Men who have sex with men
  • People who use illicit drugs (injection and non-injection)
  • People with chronic liver disease (including hepatitis B or C)
  • People with clotting factor disorders
  • People experiencing homelessness
  • Close contacts of adopted children from endemic countries
  • People with direct contact with someone who has hepatitis A
  • Laboratory workers who work with the hepatitis A virus

Post-Exposure Prevention

If you've been exposed to someone with hepatitis A and haven't been vaccinated, you may be able to prevent infection if you act quickly. Within 2 weeks of exposure:

  • Healthy people ages 1-40: Single dose of hepatitis A vaccine
  • People over 40, immunocompromised, or with chronic liver disease: May receive immune globulin (IG) along with vaccine
  • Infants under 12 months: Immune globulin (vaccine not approved for this age)

Safe Food and Water Practices

When traveling to areas where hepatitis A is common, or during local outbreaks, follow these food and water safety guidelines:

  • Drink only bottled or boiled water – this includes water for brushing teeth
  • Avoid ice unless you know it was made from safe water
  • Eat only thoroughly cooked foods served hot
  • Avoid raw fruits and vegetables unless you can peel them yourself
  • Avoid raw or undercooked shellfish
  • Don't eat food from street vendors unless it's cooked in front of you and served hot

Hand Hygiene

Thorough handwashing is one of the most effective ways to prevent hepatitis A transmission. Wash your hands with soap and water for at least 20 seconds:

  • After using the toilet
  • After changing diapers
  • Before preparing food
  • Before eating

What Are the Complications of Hepatitis A?

Most people recover completely from hepatitis A without complications. However, in rare cases, severe complications can occur, including fulminant hepatitis (acute liver failure), relapsing hepatitis, and cholestatic hepatitis (prolonged jaundice). Older adults and those with pre-existing liver disease are at higher risk.

While hepatitis A is usually a self-limiting illness with complete recovery, some people – particularly older adults and those with underlying health conditions – can develop serious complications. Understanding these potential complications helps identify warning signs that require immediate medical attention.

Fulminant Hepatitis (Acute Liver Failure)

Fulminant hepatitis is the most serious complication of hepatitis A, occurring when the liver is so severely damaged that it can no longer function. This is rare, occurring in less than 1% of cases, but it can be life-threatening. Risk factors include:

  • Age over 50 years
  • Pre-existing chronic liver disease (hepatitis B, hepatitis C, alcoholic liver disease)
  • Immunocompromised state

Warning signs of liver failure include severe fatigue, confusion or mental status changes, bleeding easily, and worsening jaundice. This is a medical emergency requiring immediate hospitalization.

Relapsing Hepatitis

About 10-15% of people with hepatitis A experience a relapse – symptoms improve initially but then return weeks or months later. Relapses can occur once or multiple times over a period of up to 6-9 months. While uncomfortable, relapsing hepatitis eventually resolves completely and does not lead to chronic infection.

Cholestatic Hepatitis

Some people develop prolonged jaundice that can last for several months. This cholestatic form of hepatitis A causes intense itching due to bile salts accumulating in the skin. While unpleasant, it typically resolves completely without long-term liver damage.

Hepatitis A and Pregnancy

Hepatitis A during pregnancy generally does not affect the fetus, but it can cause complications for the mother. The virus rarely crosses the placenta. If a pregnant woman is infectious at the time of delivery, there is a small risk the baby may contract the infection, though they typically remain asymptomatic.

Pregnant women can safely receive the hepatitis A vaccine if they're at risk of exposure. The benefits of protection outweigh any theoretical risks. If you're pregnant and become infected with hepatitis A, close monitoring by your healthcare provider is important to ensure both your health and your baby's wellbeing.

Frequently Asked Questions About Hepatitis A

Medical References and Sources

This article is based on current medical research and international guidelines. All claims are supported by scientific evidence from peer-reviewed sources.

  1. World Health Organization (2022). "Hepatitis A vaccines: WHO position paper." Weekly Epidemiological Record WHO recommendations for hepatitis A vaccination. Evidence level: 1A
  2. Centers for Disease Control and Prevention (2024). "Prevention of Hepatitis A Through Active or Passive Immunization." CDC Hepatitis A Information Comprehensive guidelines on hepatitis A prevention and immunization.
  3. American Association for the Study of Liver Diseases (2023). "AASLD Practice Guidelines." AASLD Guidelines Clinical guidelines for liver disease management.
  4. Lemon SM, et al. (2023). "Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention." Journal of Hepatology. Comprehensive review of hepatitis A biology and epidemiology.
  5. Global Burden of Disease Study (2024). "Hepatitis A epidemiology and trends." IHME Global Burden of Disease Global epidemiological data on hepatitis A.
  6. European Centre for Disease Prevention and Control (2024). "Hepatitis A - Annual Epidemiological Report." ECDC Surveillance data on hepatitis A in Europe.

Evidence grading: This article uses the GRADE framework (Grading of Recommendations Assessment, Development and Evaluation) for evidence-based medicine. Evidence level 1A represents the highest quality of evidence, based on systematic reviews of randomized controlled trials.

⚕️

iMedic Medical Editorial Team

Specialists in gastroenterology, hepatology and infectious diseases

Our Editorial Team

iMedic's medical content is produced by a team of licensed specialist physicians and medical experts with solid academic background and clinical experience. Our editorial team includes:

Gastroenterologists

Licensed physicians specializing in digestive system diseases, including liver conditions and viral hepatitis.

Infectious Disease Specialists

Experts in viral infections, epidemiology, and public health measures including vaccination.

Hepatologists

Liver specialists with expertise in all forms of hepatitis and liver disease management.

Medical Review

Independent review panel that verifies all content against international medical guidelines and current research.

Qualifications and Credentials
  • Licensed specialist physicians with international specialist competence
  • Members of AASLD (American Association for the Study of Liver Diseases)
  • Documented research background with publications in peer-reviewed journals
  • Continuous education according to WHO and international medical guidelines
  • Follows the GRADE framework for evidence-based medicine

Transparency: Our team works according to strict editorial standards and follows international guidelines for medical information. All content undergoes multiple peer review before publication.

iMedic Editorial Standards

📋 Peer Review Process

All medical content is reviewed by at least two licensed specialist physicians before publication.

🔍 Fact-Checking

All medical claims are verified against peer-reviewed sources and international guidelines.

🔄 Update Frequency

Content is reviewed and updated at least every 12 months or when new research emerges.

✏️ Corrections Policy

Any errors are corrected immediately with transparent changelog. Read more

Medical Editorial Board: iMedic has an independent medical editorial board consisting of specialist physicians in gastroenterology, hepatology, infectious diseases, and public health.